PHIO vs. GOLY
PHIO (Phio Pharmaceuticals Corp.) is a stock, while GOLY (Strategy Shares Gold-Hedged Bond ETF) is Nontraditional Bonds fund tracking the Solactive Gold-Backed Bond Index. Over the past 5 years, PHIO returned -66.25%/yr vs 5.64%/yr for GOLY. At a 0.08 correlation, their price movements are largely independent.
Performance
PHIO vs. GOLY - Performance Comparison
Loading charts...
Returns By Period
PHIO
- 1D
- 1.94%
- 1M
- -3.67%
- YTD
- 0.00%
- 6M
- -4.55%
- 1Y
- -53.64%
- 3Y*
- -65.93%
- 5Y*
- -66.25%
- 10Y*
- -69.90%
GOLY
- 1D
- -1.69%
- 1M
- -8.50%
- YTD
- -24.89%
- 6M
- -27.50%
- 1Y
- -9.04%
- 3Y*
- 15.20%
- 5Y*
- 5.64%
- 10Y*
- —
PHIO vs. GOLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PHIO Phio Pharmaceuticals Corp. | 0.00% | -41.67% | -73.68% | -82.97% | -62.80% | -50.50% |
GOLY Strategy Shares Gold-Hedged Bond ETF | -24.89% | 57.98% | 19.82% | 12.74% | -19.96% | -1.40% |
Correlation
The correlation between PHIO and GOLY is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since May 18, 2021 | 0.08 |
The correlation between PHIO and GOLY shifts across timeframes, from 0.08 (all time) to 0.21 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PHIO vs. GOLY — Risk / Return Rank
PHIO
GOLY
PHIO vs. GOLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Phio Pharmaceuticals Corp. (PHIO) and Strategy Shares Gold-Hedged Bond ETF (GOLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PHIO | GOLY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.40 | ||
| Sortino ratioReturn per unit of downside risk | -0.74 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 0.98 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | -0.25 | -0.53 |
| Martin ratioReturn relative to average drawdown | -1.15 | -0.60 | -0.55 |
Loading charts...
Drawdowns
PHIO vs. GOLY - Drawdown Comparison
The maximum PHIO drawdown since its inception was -100.00%, which is greater than GOLY's maximum drawdown of -36.08%. Use the drawdown chart below to compare losses from any high point for PHIO and GOLY.
Loading charts...
Drawdown Indicators
| PHIO | GOLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -36.08% | -63.92% |
Max Drawdown (1Y)Largest decline over 1 year | -68.73% | -36.08% | -32.65% |
Max Drawdown (3Y)Largest decline over 3 years | -96.83% | -36.08% | -60.75% |
Max Drawdown (5Y)Largest decline over 5 years | -99.67% | -36.08% | -63.59% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -35.19% | -64.81% |
Average DrawdownAverage peak-to-trough decline | -91.64% | -12.06% | -79.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.65% | 14.99% | +31.66% |
Volatility
PHIO vs. GOLY - Volatility Comparison
Phio Pharmaceuticals Corp. (PHIO) has a higher volatility of 12.84% compared to Strategy Shares Gold-Hedged Bond ETF (GOLY) at 9.36%. This indicates that PHIO's price experiences larger fluctuations and is considered to be riskier than GOLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PHIO | GOLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.84% | 9.36% | +3.48% |
Volatility (6M)Calculated over the trailing 6-month period | 63.21% | 30.58% | +32.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.68% | 33.78% | +46.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 183.83% | 22.57% | +161.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 150.13% | 22.42% | +127.71% |
Dividends
PHIO vs. GOLY - Dividend Comparison
PHIO has not paid dividends to shareholders, while GOLY's dividend yield for the trailing twelve months is around 9.80%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
GOLY Strategy Shares Gold-Hedged Bond ETF | 9.80% | 7.22% | 3.85% | 2.94% | 2.57% | 1.11% |
PHIO Phio Pharmaceuticals Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
PHIO and GOLY have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PHIO has higher volatility (12.84%) compared to GOLY (9.36%). In terms of maximum drawdown, PHIO dropped -100.00% vs GOLY's -36.08%.
GOLY currently has the higher Sharpe Ratio (-0.27 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PHIO and GOLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer